JAMA Ophthalmology has published a new article by Jeff Todd, Prevent Blindness President and CEO and Kira Baldonado, MPH, Prevent Blindness Vice President of Public Health and Policy. The Most Urgent Voice in Eye Research—The Patient’s, addresses the importance of engaging patients early and often across the research development timeline for new medicines and treatments. It also highlights the importance of patient advocacy programs like the Prevent Blindness ASPECT Program.
Read the full JAMA Ophthalmology article online.
Read more about the history of Prevent Blindness.
Read more about the Prevent Blindness ASPECT Patient Engagement Program.
